QA: Dogwood Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818844_2024_Dogwood_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001818844, Dogwood Therapeutics Inc

  xvar xval
0 AssetsCurrent 4,165,442
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 358,548
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,718,841
9 ResearchAndDevelopmentExpense 1,728,078
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 150,904
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,165,442
1 Liabilities 358,548
2 Expenses 5,446,919
3 Revenues 0
4 StockholdersEquity 3,806,894
5 NetIncome -5,296,015
6 ComprehensiveNetIncome -5,296,015
7 BaseVar 5,060,906
8 EconomicCapitalRatiobeforeLimitedLiability 1.33
9 EconomicCapitalRatio 2.55

Edgar->Model Mapping

Feature Distribution

Change over Time